Literature DB >> 19099350

Management of metastatic renal cell carcinoma: current trends.

Aza Mohammed1, Iqbal Shergill, Brian Little.   

Abstract

Renal cell carcinoma is one of the common malignancies of the genitourinary tract. In approximately one third of patients, distant metastases are present at the time of initial diagnosis and in another third, the tumor will recur even after nephrectomy with a curative intent. Renal cell carcinoma is resistant to all conventional treatment modalities of cancer, including radiotherapy and chemotherapy. We review the management of patients with metastatic renal cell carcinoma in the era of the new targeted therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19099350     DOI: 10.1586/14737159.9.1.75

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  11 in total

1.  Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.

Authors:  Liguo Lin; Kaihua Zhong; Zhongkai Sun; Guozhong Wu; Guodong Ding
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-24       Impact factor: 4.553

2.  Rap2B promotes migration and invasion of human suprarenal epithelioma.

Authors:  Jie-Hui Di; De-Bao Qu; Zheng Lu; Lian-Tao Li; Qian Cheng; Yong Xin; Long-Zhen Zhang; Yanping Zhang; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2014-06-21

3.  Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.

Authors:  Z-G Shi; S-Q Li; Z-J Li; X-J Zhu; P Xu; G Liu
Journal:  Clin Transl Oncol       Date:  2014-07-16       Impact factor: 3.405

4.  The effect of methylated oligonucleotide targeting Ki-67 gene in human 786-0 renal carcinoma cells.

Authors:  Xue-Qin Li; Dong-Sheng Pei; Guo-Wei Qian; Xiao-Xing Yin; Qian Cheng; Lian-Tao Li; Hui-Zhong Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2011-05-20

5.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

6.  MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.

Authors:  Elizabeth Ellen Jones; Thomas W Powers; Benjamin A Neely; Lisa H Cazares; Dean A Troyer; Alexander S Parker; Richard R Drake
Journal:  Proteomics       Date:  2014-03-03       Impact factor: 3.984

7.  Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure.

Authors:  Nizar M Tannir; Yu-Ning Wong; Christian K Kollmannsberger; Marc S Ernstoff; David J Perry; Leonard J Appleman; Edwin M Posadas; Daniel Cho; Toni K Choueiri; Andrew Coates; Neeraj Gupta; Rajendra Pradhan; Jiang Qian; Jihong Chen; Frank A Scappaticci; Justin L Ricker; Dawn M Carlson; M Dror Michaelson
Journal:  Eur J Cancer       Date:  2011-11-10       Impact factor: 9.162

8.  Expression and significance of histone H3K27 demethylases in renal cell carcinoma.

Authors:  Yongqing Shen; Xiaoqiang Guo; Yuejia Wang; Wei Qiu; Yanzhong Chang; Aili Zhang; Xianglin Duan
Journal:  BMC Cancer       Date:  2012-10-12       Impact factor: 4.430

9.  Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.

Authors:  Xuliang Wang; Xiaoqiang Guo; Wenshui Yu; Cailing Li; Yaoting Gui; Zhiming Cai
Journal:  BMC Cancer       Date:  2014-03-17       Impact factor: 4.430

10.  Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation.

Authors:  Yongqing Shen; Dan Yu; Pan Qi; Xuliang Wang; Xiaoqiang Guo; Aili Zhang
Journal:  Oncotarget       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.